Skip to content
Recall Observatory FDA recall evidence

Device product

Shuttle Select Slip-Cath Catheter, Intravascular, Diagnostic The catheters are intended for use in angiographic procedures by physicians trained and experienced in angiographic techniques

Z-2613-2016

April 15, 2016

Class II

Product summary

Firm
Cook Inc.
Event
Event 74010
Status
Terminated
Classification
Class II
Quantity
60,302
Official record key
device-enforcement:Z-2613-2016

Official wording

Reason: Increase in reports of polymer degradation of the catheter tip, resulting in tip fracture and/or separation. degradation could include loss of device function, separation of a device segment leading to medical intervention, or complications resulting from a separated segment. Such complications include device fragments in the vascular system, genitourinary system, or other soft tissues. Fragments within the vascular system could result in embolization to the heart or lungs, or occluding blood flow to end organs.

Code information: All Lots. Catalog prefixes/suffixes SCBR5.5-/-SHTL SCBR6.5-/-SHTL Catalog/product number; Global/order number SCBR5.5-35-125-P-NS-H1-SHTL G31129 SCBR5.5-35-125-P-NS-JB1-SHTL G31130 SCBR5.5-35-125-P-NS-JB2-SHTL G36361 SCBR5.5-35-125-P-NS-MPA-SHTL G23697 SCBR5.5-35-125-P-NS-SIM1-SHTL G23699 SCBR5.5-35-125-P-NS-SIM2-SHTL G36360 SCBR5.5-35-125-P-NS-VERT-SHTL G23698 SCBR5.5-35-125-P-NS-VTK-SHTL G36359 SCBR5.5-35-135-P-NS-ANG-SHTL G48154 SCBR5.5-35-150-P-NS-0-SHTL G23705 SCBR5.5-35-150-P-NS-ANG-SHTL G23704 SCBR5.5-35-75-P-NS-ANG-SHTL G48152 SCBR6.5-35-125-P-NS-H1-SHTL G31134 SCBR6.5-35-125-P-NS-JB1-SHTL G31135 SCBR6.5-35-125-P-NS-JB2-SHTL G36364 SCBR6.5-35-125-P-NS-SIM1-SHTL G23701 SCBR6.5-35-125-P-NS-SIM2-SHTL G36363 SCBR6.5-35-125-P-NS-VERT-SHTL G23700 SCBR6.5-35-125-P-NS-VTK-SHTL G36362

Distribution pattern: Worldwide Distribution - US (Nationwide) and Internationally to Algeria, Andorra, Argentina, Armenia, Australia, Austria, Bahrain, Bangladesh, Barbados, Belgium, Bermuda, Brazil, Brunei Darussalam, Bulgaria, Canada, Canary Islands, Chile, China, Colombia, Costa Rica, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Ecuador, Egypt, El Salvador, Finland, France, French Polynesia, Georgia, Germany, Greece, Guadeloupe, Guatemala, Guernsey, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jersey, Jordan, Kazakhstan, Kenya, Korea, Kosovo, Kuwait, Latvia, Lebanon, Libyan Arab Jamahiriya, Lithuania, Luxembourg, Macau, Malaysia, Malta, Martinique, Mauritius, Mexico, Monaco, Mongolia, Morocco, Myanmar, Netherlands, Netherlands Antilles, New Caledonia, New Zealand, Nicaragua, Norway, Oman, Pakistan, "Palestinian Territory, Occupied", Panama, Paraguay, Peru, Philippines, Poland, Portugal, Puerto Rico, Qatar, Reunion, Romania, Russian Federation, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Thailand, Trinidad And Tobago, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Venezuela, Vietnam, U.S. Virgin Islands, Yugoslavia.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Increase in reports of polymer degradation of the catheter tip, resulting in tip fracture and/or separation. degradation could include loss of device function, separation of a device segment leading to medical intervention, or complications resulting from a separated segment. Such complications include device fragments in the vascular system, genitourinary system, or other soft tissues. Fragments within the vascular system could result in embolization to the heart or lungs, or occluding blood flow to end organs.